Symbiosis Pharmaceutical Services

About Symbiosis Pharmaceutical Services

Symbiosis Pharmaceutical Services is a contract development and manufacturing organisation (CDMO) that specialises in the GMP manufacture and sterile fill/finish of vials for clinical trials and commercial sales globally. Regulatory compliance, technical capability and operational flexibility are at our core. Manufacturing takes place in purpose-built MHRA-licensed and FDA approved facilities, enabling the CDMO to handle products that require aseptic liquid filling and lyophilisation for a range of complex biologics, viral vectors for use in gene therapies and small molecule drugs. Offering rapid access to manufacturing slots and accelerated release of drug product, Symbiosis is primed to meet demand for fast-turnaround drug product manufacturing, while maintaining regulatory compliance to the highest standards. Symbiosis specialises in the sterile fill/finish of biologic and small molecule products into vials, which are either liquid or lyophilised formulations. Capabilities include the ability to handle and fill antibodies, proteins, peptides, nucleic acids, cytotoxic, cytostatic and highly potent APIs including ADCs along with conventional small molecules. Symbiosis saves our clients invaluable development time. With short lead times to manufacture and faster release of sterile drug product, we help get your drug product to clinical trial or ready commercial sale faster. Our focus is service excellence through flexibility, responsiveness and timeliness. If you need a drug filled aseptically, come and speak with Symbiosis...we will exceed your expectations.